Thermo Fisher Scientific Inc.
NYSE:TMO 10:42:55 AM EDT
Other Pre-Announcement
Thermo Fisher Scientific Reports Q4 And FY 2022 Results
Published: 02/01/2023 12:05 GMT
Thermo Fisher Scientific Inc. (TMO) - Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2022 Results.
Expects to Achieve 2023 Revenue of $45.3 Billion and Full Year Core Organic Revenue Growth of 7%.
Expects to Achieve Adjusted EPS of $23.70 in 2023.
Qtrly Laboratory Products and Biopharma Services Segment Revenue $5,947 Million Versus $4,195 Million.
Qtrly Specialty Diagnostics Segment Revenue of $1,115 Million Versus $ 1,447 Million.
Q4 Earnings per Share View $5.20, Revenue View $10.43 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2023 Earnings per Share View $23.22, Revenue View $43.99 Billion -- Refinitiv Ibes Data (analyst estimates).
Expects to Achieve 2023 Revenue of $45.3 Billion and Full Year Core Organic Revenue Growth of 7%.
Expects to Achieve Adjusted EPS of $23.70 in 2023.
Qtrly Laboratory Products and Biopharma Services Segment Revenue $5,947 Million Versus $4,195 Million.
Qtrly Specialty Diagnostics Segment Revenue of $1,115 Million Versus $ 1,447 Million.
Q4 Earnings per Share View $5.20, Revenue View $10.43 Billion -- Refinitiv Ibes Data (analyst estimates).
FY2023 Earnings per Share View $23.22, Revenue View $43.99 Billion -- Refinitiv Ibes Data (analyst estimates).